Address

Novartis Venture Funds
Novartis International AG WSJ-200.220 P.O. Box
4002 Basel
Switzerland

Open map


Recent investment activity

KANDO id: 30987

Corporate information

Official name
Novartis International AG
Registration country

Company type

The corporate venturing arm of Novartis.

Funding rounds

Actual initial investment stage
Seed (1)
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 49
Profile Country Date Funding
Alnylam Pharmaceuticals Inc N/A
Anchor Therapeutics Inc Series B
Ascent Therapeutics Inc Series A
Autonomic Technologies Inc N/A
Avila Therapeutics Inc A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'. N/A
Biofisica Inc Wound care company. Series A
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series C
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series B
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. Series A
Celladon Corp N/A
Cequent Pharmaceuticals Series A
FoldRx Pharmaceuticals Inc N/A
Forma Therapeutics Inc N/A
Heptares Therapeutics Ltd Series A
Intradigm Corp Series B
Intradigm Corp Series A
IRX Therapeutics Inc N/A
LigoCyte Pharmaceuticals Inc N/A
Lumenos Inc Provider of consumer-driven health care plans. N/A
Nereus Pharmaceuticals Inc N/A
Nereus Pharmaceuticals Inc Series B
Okairos AG N/A
Panomics Inc Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner N/A
PharmAbcine Inc Develops fully human therapeutic monoclonal antibody (mAb) Series A
Portaero Inc N/A

Past employees

Selected Products / Customers

Financials